TLX · NASDAQ
Telix Pharmaceuticals (TLX) Stock Price & Fundamentals
$645.99+0.25%+$1.61End-of-day price as of Oct 9, 2026
Sample prices
Prices on this page are generated sample data for development, not real market data, so market cap, P/E and dividend yield are illustrative too.
Telix Pharmaceuticals (TLX) closed at $645.99 on Oct 9, 2026, up 0.25% from the previous close of $644.38.
Share price, past year
1Y +15.07%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $645.99 |
| Sep 30, 2026 | $630.90 |
| Aug 31, 2026 | $636.46 |
| Jul 31, 2026 | $604.18 |
| Jun 30, 2026 | $597.61 |
| May 29, 2026 | $594.25 |
| Apr 30, 2026 | $597.65 |
| Mar 31, 2026 | $601.23 |
| Feb 27, 2026 | $618.71 |
| Jan 30, 2026 | $590.13 |
| Dec 31, 2025 | $562.54 |
| Nov 28, 2025 | $575.13 |
| Oct 31, 2025 | $577.83 |
Key statistics
- 52-week range
- $549.01 – $650.20
Financials
Telix Pharmaceuticals reports to the SEC in international accounting standards (IFRS), which Laurel doesn't show yet.
Company profile
- Name
- Telix Pharmaceuticals Ltd
- Ticker
- TLX
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 55 Flemington Road, North Melbourne, C3 3051
- Incorporated in
- C3
- Fiscal year ends
- December
- SEC CIK
- 0002007191
Frequently asked questions
What is Telix Pharmaceuticals's stock price?
Telix Pharmaceuticals (TLX) closed at $645.99 on Oct 9, 2026, up 0.25% from the previous close of $644.38.
Sources and methodology
Fundamentals come from Telix Pharmaceuticals Ltd's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures